Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) Research & Development (2016 - 2025)

Innoviva (INVA) has disclosed Research & Development for 14 consecutive years, with $9.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 164.71% year-over-year to $9.4 million, compared with a TTM value of $25.3 million through Sep 2025, down 39.04%, and an annual FY2025 reading of $30.6 million, up 124.14% over the prior year.
  • Research & Development was $9.4 million for Q3 2025 at Innoviva, up from $8.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $31.6 million in Q3 2023 and bottomed at $38000.0 in Q2 2021.
  • Average Research & Development over 5 years is $9.5 million, with a median of $5.8 million recorded in 2022.
  • The sharpest move saw Research & Development plummeted 93.2% in 2021, then soared 36436.84% in 2022.
  • Year by year, Research & Development stood at $449000.0 in 2021, then skyrocketed by 6903.79% to $31.4 million in 2022, then rose by 0.38% to $31.6 million in 2023, then crashed by 88.75% to $3.6 million in 2024, then soared by 164.71% to $9.4 million in 2025.
  • Business Quant data shows Research & Development for INVA at $9.4 million in Q3 2025, $8.0 million in Q2 2025, and $4.4 million in Q1 2025.